Free Trial

CareCloud (CCLD) Competitors

CareCloud logo
$2.26 -0.17 (-6.82%)
As of 03:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CCLD vs. CTEV, AMWL, OPRX, DH, and HCAT

Should you buy CareCloud stock or one of its competitors? CareCloud's main competitors and comparable companies include Claritev (CTEV), American Well (AMWL), OptimizeRx (OPRX), Definitive Healthcare (DH), and Health Catalyst (HCAT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does CareCloud compare to Claritev?

Claritev (NYSE:CTEV) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

Claritev has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

87.2% of Claritev shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 7.4% of Claritev shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Claritev had 1 more articles in the media than CareCloud. MarketBeat recorded 22 mentions for Claritev and 21 mentions for CareCloud. Claritev's average media sentiment score of 0.97 beat CareCloud's score of 0.66 indicating that Claritev is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Claritev
9 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareCloud
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

CareCloud has a net margin of 7.36% compared to Claritev's net margin of -27.05%. CareCloud's return on equity of 36.92% beat Claritev's return on equity.

Company Net Margins Return on Equity Return on Assets
Claritev-27.05% N/A -5.74%
CareCloud 7.36%36.92%16.40%

CareCloud has lower revenue, but higher earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Claritev$1.02B0.45-$284.28M-$16.42N/A
CareCloud$120.50M0.85$10.80M$0.1318.62

Claritev currently has a consensus target price of $44.83, indicating a potential upside of 66.73%. Given Claritev's stronger consensus rating and higher possible upside, analysts plainly believe Claritev is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Claritev
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

CareCloud beats Claritev on 9 of the 16 factors compared between the two stocks.

How does CareCloud compare to American Well?

CareCloud (NASDAQ:CCLD) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

CareCloud has higher earnings, but lower revenue than American Well. American Well is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.85$10.80M$0.1318.62
American Well$211.23M0.96-$95.70M-$3.44N/A

In the previous week, CareCloud had 21 more articles in the media than American Well. MarketBeat recorded 21 mentions for CareCloud and 0 mentions for American Well. American Well's average media sentiment score of 1.00 beat CareCloud's score of 0.66 indicating that American Well is being referred to more favorably in the news media.

Company Overall Sentiment
CareCloud Positive
American Well Positive

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 56.0% of American Well shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 12.8% of American Well shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CareCloud has a net margin of 7.36% compared to American Well's net margin of -27.03%. CareCloud's return on equity of 36.92% beat American Well's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud7.36% 36.92% 16.40%
American Well -27.03%-24.32%-17.91%

American Well has a consensus target price of $12.30, indicating a potential upside of 4.41%. Given American Well's higher probable upside, analysts plainly believe American Well is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
American Well
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

CareCloud has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market. Comparatively, American Well has a beta of 1.72, suggesting that its share price is 72% more volatile than the broader market.

Summary

CareCloud beats American Well on 9 of the 15 factors compared between the two stocks.

How does CareCloud compare to OptimizeRx?

CareCloud (NASDAQ:CCLD) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

OptimizeRx has a consensus price target of $11.21, suggesting a potential upside of 52.78%. Given OptimizeRx's stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
OptimizeRx
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56

In the previous week, OptimizeRx had 3 more articles in the media than CareCloud. MarketBeat recorded 24 mentions for OptimizeRx and 21 mentions for CareCloud. CareCloud's average media sentiment score of 0.66 beat OptimizeRx's score of 0.26 indicating that CareCloud is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
OptimizeRx
2 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 14.8% of CareCloud shares are owned by insiders. Comparatively, 7.5% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CareCloud has a net margin of 7.36% compared to OptimizeRx's net margin of 5.33%. CareCloud's return on equity of 36.92% beat OptimizeRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud7.36% 36.92% 16.40%
OptimizeRx 5.33%9.58%7.47%

CareCloud has higher revenue and earnings than OptimizeRx. CareCloud is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.85$10.80M$0.1318.62
OptimizeRx$109.43M1.26$5.13M$0.2529.36

CareCloud has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market.

Summary

CareCloud and OptimizeRx tied by winning 8 of the 16 factors compared between the two stocks.

How does CareCloud compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, CareCloud had 18 more articles in the media than Definitive Healthcare. MarketBeat recorded 21 mentions for CareCloud and 3 mentions for Definitive Healthcare. CareCloud's average media sentiment score of 0.66 beat Definitive Healthcare's score of 0.46 indicating that CareCloud is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareCloud
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CareCloud has a net margin of 7.36% compared to Definitive Healthcare's net margin of -69.18%. CareCloud's return on equity of 36.92% beat Definitive Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-69.18% 4.35% 1.84%
CareCloud 7.36%36.92%16.40%

Definitive Healthcare presently has a consensus target price of $1.47, suggesting a potential upside of 12.32%. Given Definitive Healthcare's higher possible upside, research analysts plainly believe Definitive Healthcare is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
3 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Definitive Healthcare has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

CareCloud has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$241.52M0.58-$138.93M-$1.50N/A
CareCloud$120.50M0.85$10.80M$0.1318.62

Summary

CareCloud beats Definitive Healthcare on 12 of the 16 factors compared between the two stocks.

How does CareCloud compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment and profitability.

In the previous week, CareCloud had 14 more articles in the media than Health Catalyst. MarketBeat recorded 21 mentions for CareCloud and 7 mentions for Health Catalyst. CareCloud's average media sentiment score of 0.66 beat Health Catalyst's score of 0.41 indicating that CareCloud is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health Catalyst
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareCloud
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Health Catalyst currently has a consensus target price of $2.01, suggesting a potential upside of 33.00%. Given Health Catalyst's higher probable upside, research analysts plainly believe Health Catalyst is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

CareCloud has a net margin of 7.36% compared to Health Catalyst's net margin of -74.24%. CareCloud's return on equity of 36.92% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-74.24% -4.84% -2.02%
CareCloud 7.36%36.92%16.40%

CareCloud has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$272.21M0.42-$177.97M-$2.83N/A
CareCloud$120.50M0.85$10.80M$0.1318.62

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 14.8% of CareCloud shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Health Catalyst has a beta of 1.52, suggesting that its share price is 52% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market.

Summary

CareCloud beats Health Catalyst on 12 of the 16 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCLD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCLD vs. The Competition

MetricCareCloudHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$95.52M$1.97B$7.84B$11.78B
Dividend YieldN/A3.89%2.47%4.41%
P/E Ratio17.2742.0234.3430.14
Price / Sales0.735.118.085.36
Price / Cash3.5115.7621.0222.32
Price / Book1.615.774.783.86
Net Income$10.80M-$19.09M$3.52B$391.27M
7 Day Performance-10.16%-6.77%-4.96%-4.25%
1 Month Performance21.89%-4.89%-3.18%-5.57%
1 Year Performance-27.96%-11.61%-0.28%-7.49%

CareCloud Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCLD
CareCloud
2.4672 of 5 stars
$2.26
-6.8%
N/A-22.7%$95.52M$131.30M17.273,650
CTEV
Claritev
4.5034 of 5 stars
$24.36
+1.5%
$44.83
+84.0%
-38.1%$412.90M$965.41MN/A3,000
AMWL
American Well
2.6087 of 5 stars
$11.67
-6.3%
$12.30
+5.4%
+192.7%$193.80M$249.32MN/A562
OPRX
OptimizeRx
4.148 of 5 stars
$9.11
-3.8%
$11.57
+27.0%
-51.6%$171.61M$109.43M39.61105
DH
Definitive Healthcare
2.8106 of 5 stars
$1.15
+2.2%
$1.47
+28.5%
-52.2%$122.23M$241.52MN/A686

Related Companies and Tools


This page (NASDAQ:CCLD) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners